风险分层临床路径缩短胰腺切除术后住院时间并降低围术期费用
研究制定并实施按术后胰瘘风险分层的胰腺切除临床路径(低危胰十二指肠切除、高危胰十二指肠切除、远端胰腺切除),与实施前连续患者比较。结果显示胰腺切除术后中位住院时间由10天降至6天(P < .001),指数住院中位费用下降22%,90天不良事件、B/C级术后胰瘘、非家庭出院及再入院率未见变化。
要点
- 风险分层胰腺切除临床路径使中位住院时间由10天降至6天(P < .001)。
- 指数住院中位费用下降22%,低危胰十二指肠切除与远端胰腺切除改善更明显。
- 90天不良事件、B/C级胰瘘、出院去向及再入院率未见变化。
核心结论
- 实施风险分层胰腺切除临床路径可降低胰腺切除术后中位住院时间和指数住院费用,且未对围术期不良事件率、再入院率或出院去向产生不利影响。
- 低危胰十二指肠切除和远端胰腺切除的结局改善最为有利;高危胰十二指肠切除仍需进一步工作以降低术后胰瘘率、减少变异并改善结局。
研究设计与样本
- 制定并实施三条风险分层胰腺切除临床路径:低危胰十二指肠切除、高危胰十二指肠切除和远端胰腺切除。
- 将实施后的连续患者与实施前立即治疗的患者进行比较,评估住院时间、围术期不良事件率、出院去向、再入院及医疗费用。
主要发现
- 胰腺切除术后中位住院时间由10天降至6天(P < .001)。
- 指数住院中位费用下降22%。
- 低危胰十二指肠切除(P < .05)和远端胰腺切除(P < .05)的中位住院时间与住院费用变化呈下降,高危胰十二指肠切除则未见此变化。
- 实施后90天不良事件率、B/C级术后胰瘘率、非家庭出院率及再入院率均无变化。
临床怎么用
- 对低危胰十二指肠切除和远端胰腺切除患者可优先采用风险分层临床路径以缩短住院时间并降低费用。
- 高危胰十二指肠切除患者应用该路径时需继续关注术后胰瘘及结局改善。
- 路径实施时应同步监测不良事件、再入院和出院去向,确认安全性不受影响。
局限性
- 研究为实施前后连续患者比较,非随机对照设计。
- 高危胰十二指肠切除患者的住院时间与费用未见显著改善,路径对该亚组的效果有限。
- 摘要未报告样本量、置信区间及除P值外的具体统计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative pancreatic fistula is associated with adverse events, increased duration of stay and hospital costs. We developed perioperative care pathways stratified by postoperative pancreatic fistula risk with the aims of minimizing variations in care, improving quality, and decreasing costs. STUDY DESIGN: Three unique risk-stratified pancreatectomy clinical pathways-low-risk pancreatoduodenectomy, high-risk pancreatoduodenectomy, and distal pancreatectomy were developed and implemented. Consecutive patients treated after implementation of the risk-stratified pancreatectomy clinical pathways were compared with patients treated immediately prior. Duration of stay, rates of perioperative adverse effects, discharge disposition, and hospital readmission, as well as the associated costs of care, were evaluated. RESULTS: The median hospital stay after pancreatectomy decreased from 10 to 6 days after implementation of the risk-stratified pancreatectomy clinical pathways (P < .001), and the median cost of index hospitalization decreased by 22%. Decreased changes in median hospital stay and costs of hospitalization were observed in association with low-risk pancreatoduodenectomy (P < .05) and distal pancreatectomy (P < .05), but not high-risk pancreatoduodenectomy. The rates of 90-day adverse events, grade B/C postoperative pancreatic fistula, discharge to a facility other than home, or readmission did not change after implementation. CONCLUSION: Implementation of risk-stratified pancreatectomy clinical pathways decreased median stay and cost of index hospitalization after pancreatectomy without unfavorably affecting rates of perioperative adverse events or readmission, or discharge disposition. Outcomes were most favorably improved for low-risk pancreatoduodenectomy and distal pancreatectomy. Additional work is necessary to decrease the rate of postoperative pancreatic fistula, minimize variability, and improve outcomes after high-risk pancreatoduodenectomy.
引用
- Denbo JW, Bruno M, Dewhurst W, et al. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018. PMID: 29807648. doi:10.1016/j.surg.2018.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。